SCHEMBL3976137

SCHEMBL3976137

CCCCc1ccc(-c2ccoc2C(=O)NN)cc1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GCGR P47871 1/20 0.53
AGTR1 P30556 1/20 0.47
AGTR2 P50052 1/20 0.47
RARB P10826 6/20 0.46
PLK1 P53350 1/20 0.46
ALDH1A1 P00352 2/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TRPV1 Q8NER1 1/20 0.41
TP53 P04637 1/20 0.41
GAA P10253 1/20 0.41
MEN1 O00255 1/20 0.40
RARA P10276 1/20 0.40
MAPT P10636 1/20 0.40
MTOR P42345 1/20 0.40
KMT2A Q03164 1/20 0.40
F13A1 P00488 1/20 0.40
TGM2 P21980 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975792 0.74 GCGR (0.95) GCGRAGTR1AGTR2RARBPLK1
SCHEMBL12951705 0.74 ALDH1A1 (0.61) ALDH1A1TP53MAPT
SCHEMBL12951708 0.73 ALDH1A1 (0.41) GCGRALDH1A1HPGDHSD17B10MEN1
SCHEMBL19443009 0.73 PLK1 (0.74) RARBPLK1ALDH1A1HPGDHSD17B10
SCHEMBL3976519 0.71 NPC1 (0.44) ALDH1A1HPGDTP53GAAMEN1
SCHEMBL4189932 0.70 RARB (0.69) RARBPLK1ALDH1A1MEN1RARA
SCHEMBL3982443 0.70 NPSR1 (0.43) ALDH1A1HSD17B10GAAMEN1MAPT
SCHEMBL2747801 0.68 PLK1 (0.67) RARBPLK1ALDH1A1TRPV1MEN1
SCHEMBL4824490 0.67 PLK1 (0.65) RARBPLK1ALDH1A1MEN1RARA
SCHEMBL9206725 0.67 PLK1 (0.65) RARBPLK1ALDH1A1MEN1RARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 GCGR 2/4885AGTR1 48/4885AGTR2 41/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.